東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Understanding the Potential of Micro...

Lim, Lionel.

Linked to FindBook

Google Book

Amazon

博客來

Understanding the Potential of MicroRNAs as Novel Therapeutic Targets in Cancer.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Understanding the Potential of MicroRNAs as Novel Therapeutic Targets in Cancer./
Author:	Lim, Lionel.
Description:	136 p.
Notes:	Source: Dissertation Abstracts International, Volume: 74-08(E), Section: B.
Contained By:	Dissertation Abstracts International74-08B(E).
Subject:	Biology, General. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3558427
ISBN:	9781303028724

Understanding the Potential of MicroRNAs as Novel Therapeutic Targets in Cancer.
Lim, Lionel.

Understanding the Potential of MicroRNAs as Novel Therapeutic Targets in Cancer. - 136 p.

Source: Dissertation Abstracts International, Volume: 74-08(E), Section: B.

Thesis (Ph.D.)--University of California, San Francisco, 2013.

Cancer is a complex and heterogenous disease triggered by a myriad of genetic and lifestyle factors. Decades of research have furthered our understanding of key oncogenes, tumor suppressor genes and signaling pathways, leading to the development of numerous effective cancer therapies. However, the dysregulation of multiple signaling pathways through aberrant gene expression makes existing treatment ineffective in many cancers, including hepatocellular carcinoma (HCC) and triple negative breast cancers (TNBCs). There is thus an urgent need to explore and develop novel therapeutics for the treatment of these widespread and fatal cancers. It is well established that microRNAs (miRNAs) are key players in both HCC and TNBC development, and exhibit aberrant processing and expression profiles in these cancers. Because a single miRNA could potentially affect several clinically relevant targets, artificially altering the expression level of a miRNA may effectively shut down multiple oncogenic pathways, offering effective therapeutic perspectives. In this thesis, we explored the potential of targeting an oncogenic miRNA in HCC. We find that miR-494 is upregulated in multiple mouse models and aggressive human HCC. We demonstrate that it accelerates G1/S cell cycle transition through regulation of Mutated in Colorectal Cancer (MCC) gene expression and show that its inhibition reduces transformation in human liver tumor cell lines and inhibits tumor growth in vivo. Separately, we explored the possibility of exploiting endogenous miRNA function to predict p53 expression, and consequently, therapeutic response in breast cancer. We find two SNPs in the p53 3' UTR, 485G>A and 826G>A, that are associated with mutant p53, and occur at higher frequencies in breast cancer patients than a diverse population. Further, we find that these SNPs lower p53 expression, possibly through creation of novel miRNA binding sites. Our findings indicate that miR-494 may have clinical value as a therapeutic target in HCC, and miRNA regulation of mutant p53 could be a predictor of therapeutic response in breast cancer.

ISBN: 9781303028724Subjects--Topical Terms:

1018625
Biology, General.

Understanding the Potential of MicroRNAs as Novel Therapeutic Targets in Cancer.
LDR:03027nam a2200289 4500 001 1965537
005 20141030134119.5
008 150210s2013 ||||||||||||||||| ||eng d
020 $a 9781303028724
035 $a (MiAaPQ)AAI3558427
035 $a AAI3558427
040 $a MiAaPQ $c MiAaPQ
100 1 $a Lim, Lionel. $3 2102212
245 1 0 $a Understanding the Potential of MicroRNAs as Novel Therapeutic Targets in Cancer.
300 $a 136 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-08(E), Section: B.
500 $a Adviser: Andrei Goga.
502 $a Thesis (Ph.D.)--University of California, San Francisco, 2013.
520 $a Cancer is a complex and heterogenous disease triggered by a myriad of genetic and lifestyle factors. Decades of research have furthered our understanding of key oncogenes, tumor suppressor genes and signaling pathways, leading to the development of numerous effective cancer therapies. However, the dysregulation of multiple signaling pathways through aberrant gene expression makes existing treatment ineffective in many cancers, including hepatocellular carcinoma (HCC) and triple negative breast cancers (TNBCs). There is thus an urgent need to explore and develop novel therapeutics for the treatment of these widespread and fatal cancers. It is well established that microRNAs (miRNAs) are key players in both HCC and TNBC development, and exhibit aberrant processing and expression profiles in these cancers. Because a single miRNA could potentially affect several clinically relevant targets, artificially altering the expression level of a miRNA may effectively shut down multiple oncogenic pathways, offering effective therapeutic perspectives. In this thesis, we explored the potential of targeting an oncogenic miRNA in HCC. We find that miR-494 is upregulated in multiple mouse models and aggressive human HCC. We demonstrate that it accelerates G1/S cell cycle transition through regulation of Mutated in Colorectal Cancer (MCC) gene expression and show that its inhibition reduces transformation in human liver tumor cell lines and inhibits tumor growth in vivo. Separately, we explored the possibility of exploiting endogenous miRNA function to predict p53 expression, and consequently, therapeutic response in breast cancer. We find two SNPs in the p53 3' UTR, 485G>A and 826G>A, that are associated with mutant p53, and occur at higher frequencies in breast cancer patients than a diverse population. Further, we find that these SNPs lower p53 expression, possibly through creation of novel miRNA binding sites. Our findings indicate that miR-494 may have clinical value as a therapeutic target in HCC, and miRNA regulation of mutant p53 could be a predictor of therapeutic response in breast cancer.
590 $a School code: 0034.
650 4 $a Biology, General. $3 1018625
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0306
690 $a 0307
690 $a 0992
710 2 $a University of California, San Francisco. $b Biomedical Sciences. $3 1263090
773 0 $t Dissertation Abstracts International $g 74-08B(E).
790 $a 0034
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3558427